C49 Malignant neoplasm of other connective and soft tissue - analogs
| Description «C49 Malignant neoplasm of other connective and soft tissue» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 20% Compare C49.2 Malignant neoplasm, connective and soft tissue of lower limb, including hip
- 20% Compare C49.8 Malignant neoplasm, overlapping lesion of connective and soft tissue
- 20% Compare C45-C49 Malignant neoplasms of mesothelial and soft tissues
- 20% Compare C49.5 Malignant neoplasm, connective and soft tissue of pelvis
- 20% Compare C49.6 Malignant neoplasm, connective and soft tissue of trunk, unspecified
- 13% Compare C49.4 Malignant neoplasm, connective and soft tissue of abdomen
- 13% Compare C49.0 Malignant neoplasm, connective and soft tissue of head, face and neck
- 10% Compare C65 Malignant neoplasm of renal pelvis
- 10% Compare C50.9 Malignant neoplasm, breast, unspecified
- 10% Compare C50.4 Malignant neoplasm, upper-outer quadrant of breast
- 10% Compare C50.8 Malignant neoplasm, overlapping lesion of breast
- 10% Compare C34.3 Malignant neoplasm, lower lobe, bronchus or lung
- 10% Compare C34.8 Malignant neoplasm, overlapping lesion of bronchus and lung
- 10% Compare C64 Malignant neoplasm of kidney, except renal pelvis
- 10% Compare C92.7 Other myeloid leukaemia
- 10% Compare C91.5 Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
- 10% Compare C50 Malignant neoplasm of breast
- 10% Compare C79.8 Secondary malignant neoplasm of other specified sites
- 10% Compare D48.1 Neoplasm of uncertain or unknown behaviour, connective and other soft tissue
- 10% Compare C71.1 Malignant neoplasm, frontal lobe
- 10% Compare C68.0 Malignant neoplasm, urethra
- 10% Compare C44.5 Malignant neoplasm, skin of trunk
- 10% Compare C71.2 Malignant neoplasm, temporal lobe
- 10% Compare C93 Monocytic leukaemia
- 10% Compare C92 Myeloid leukaemia
- 10% Compare D29 Benign neoplasm of male genital organs
- 10% Compare C71.3 Malignant neoplasm, parietal lobe
- 10% Compare C25 Malignant neoplasm of pancreas
- 10% Compare C30-C39 Malignant neoplasms of the respiratory and thoracic organs
- 10% Compare C60 Malignant neoplasm of penis
- 10% Compare C34.2 Malignant neoplasm, middle lobe, bronchus or lung
- 10% Compare C25.1 Malignant neoplasm, body of pancreas
- 10% Compare D21 Other benign neoplasms of connective and other soft tissue
- 10% Compare C34 Malignant neoplasm of bronchus and lung
- 10% Compare C34.0 Malignant neoplasm, main bronchus
- 10% Compare C24 Malignant neoplasm of other and unspecified parts of biliary tract
- 10% Compare C50.1 Malignant neoplasm, central portion of breast
- 10% Compare C50.5 Malignant neoplasm, lower-outer quadrant of breast
- 10% Compare C50.2 Malignant neoplasm, upper-inner quadrant of breast
- 10% Compare C25.8 Malignant neoplasm, overlapping lesion of pancreas
- 10% Compare C73 Malignant neoplasm of thyroid gland
- 10% Compare C25.2 Malignant neoplasm, tail of pancreas
- 10% Compare C09 Malignant neoplasm of tonsil
- 10% Compare C44 Other malignant neoplasms of skin
- 10% Compare C22.1 Malignant neoplasm, intrahepatic bile duct carcinoma
- 10% Compare C44.9 Malignant neoplasm of skin, unspecified
- 10% Compare C23 Malignant neoplasm of gallbladder
- 10% Compare C01 Malignant neoplasm of base of tongue
- 10% Compare C90.1 Plasma cell leukaemia
- 10% Compare C58 Malignant neoplasm of placenta
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.